Literature DB >> 28951365

[Expression of VEGF and PEDF in early-stage retinopathy in diabetic Macaca mulatta].

Jing-Fei Chen1, Qi-Hui Luo, Chao Huang, Wen-Tao Liu, Wen Zeng, Qi Gao, Ping Chen, Bing Chen, Zheng-Li Chen.   

Abstract

OBJECTIVE: To explore the expression of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in early stage of diabetic retinopathy (DR) in Macaca mulatta.
METHODS: Three diabetic Macaca mulattas induced by high-fat diet were identified for early stage of diabetic retinopathy according to the fasting plasma glucose, hemoglobin Alc (HbA1c), fundus photograph and duration of diabetes, with another 3 age-matched healthy Macaca mulattas as control. The expression of VEGF and PEDF in the retinas of Macaca mulatta were detected by quantitative real-time PCR and immunohistochemistry. RESULT: In early stage of diabetic retinopathy, VEGF mRNA and protein of the diabetic group were both significantly increased compared with the control group (P<0.05). PEDF expression at both mRNA and protein levels was significantly decreased in diabetic Macaca mulattas compared with the control group (P<0.01 and 0.05 respectively).
CONCLUSION: Retinal VEGF expression is increased and PEDF expression is decreased in early stage of diabetic retinopathy, suggesting their involvement in the occurrence of diabetic retinopathy and their value in assisting in the early diagnosis.

Entities:  

Year:  2017        PMID: 28951365      PMCID: PMC6765491     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  19 in total

1.  Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes.

Authors:  H Sone; Y Kawakami; Y Okuda; Y Sekine; S Honmura; K Matsuo; T Segawa; H Suzuki; K Yamashita
Journal:  Diabetologia       Date:  1997-06       Impact factor: 10.122

2.  Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Authors:  Jeffrey G Gross; Adam R Glassman; Lee M Jampol; Seidu Inusah; Lloyd Paul Aiello; Andrew N Antoszyk; Carl W Baker; Brian B Berger; Neil M Bressler; David Browning; Michael J Elman; Frederick L Ferris; Scott M Friedman; Dennis M Marcus; Michele Melia; Cynthia R Stockdale; Jennifer K Sun; Roy W Beck
Journal:  JAMA       Date:  2015-11-24       Impact factor: 56.272

3.  Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.

Authors:  Sho-ichi Yamagishi; Takanori Matsui; Kazuo Nakamura; Masayoshi Takeuchi; Tsutomu Imaizumi
Journal:  Microvasc Res       Date:  2006-06-22       Impact factor: 3.514

4.  Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor.

Authors:  V Stellmach; S E Crawford; W Zhou; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

5.  Antiangiogenic therapy for ischemic retinopathies.

Authors:  Motasem Al-Latayfeh; Paolo S Silva; Jennifer K Sun; Lloyd Paul Aiello
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 6.  Proliferative retinopathies: angiogenesis that blinds.

Authors:  Przemyslaw Sapieha; David Hamel; Zhuo Shao; Jose Carlos Rivera; Karine Zaniolo; Jean Sébastien Joyal; Sylvain Chemtob
Journal:  Int J Biochem Cell Biol       Date:  2009-10-15       Impact factor: 5.085

7.  Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells.

Authors:  Shali Chen; Rana Chakrabarti; Emily C Keats; Megan Chen; Subrata Chakrabarti; Zia A Khan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-17       Impact factor: 4.799

8.  Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.

Authors:  Elia J Duh; Hoseong S Yang; Julia A Haller; Eugene De Juan; Mark S Humayun; Peter Gehlbach; Michele Melia; Dante Pieramici; J B Harlan; Peter A Campochiaro; Donald J Zack
Journal:  Am J Ophthalmol       Date:  2004-04       Impact factor: 5.258

9.  Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.

Authors:  Yumiko Yoshida; Sho-Ichi Yamagishi; Takanori Matsui; Yuko Jinnouchi; Kei Fukami; Tsutomu Imaizumi; Ryoji Yamakawa
Journal:  Diabetes Metab Res Rev       Date:  2009-10       Impact factor: 4.876

Review 10.  Global prevalence and major risk factors of diabetic retinopathy.

Authors:  Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.